Stay updated on Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Sign up to get notified when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.

Latest updates to the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov study page continues to show a 403 Forbidden error, while the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, indicating access is blocked; this change hides the detailed trial information and related resources from view.SummaryDifference19%

- Check30 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0. This indicates a new revision of the underlying platform/documentation, typically an internal update rather than user-facing content changes.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision label on the page was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's template or metadata rather than to the study content.SummaryDifference0.0%

- Check51 days agoChange DetectedAn NIH grant/contract funding note for 2017 was added to the study identifiers. This clarifies the funding source associated with that entry in the study's record.SummaryDifference0.1%

Stay in the know with updates to Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.